Pegylated TNF inhibitor 'effective' in refractory RA
Investigators report a rapid and sustained clinical improvement in rheumatoid arthritis (RA) signs and symptoms when treated with a phase III long-acting pegylated TNF inhibitor....
Want to read complete article? Please Sign in or Register.